Retail Traction Meets Market Momentum

Disrupting the Future of Pest Control

*together with Med-x Inc.

Why Invest in Med-X Before the Planned Nasdaq Listing?

Med-X is gearing up for a possible Nasdaq listing (ticker: MXRX) – and for investors, the biggest potential upside comes before the bell rings.

The greatest wealth creation happens in the gap between the private and public markets. At the private stage, you buy at a fixed valuation based on fundamentals.

Once public, the market prices in future growth. That's where early investors often see the most potential dramatic appreciation.

Med-X's Setup:

  • Nasdaq ticker MXRX reserved

  • Listing qualifications nearly complete

  • Sponsored by Maxim Group Investment Bank

  • Zero debt, established revenue base

The Real Opportunity to Become a Shareholder Is Now!

Med-X is a botanical pesticide company replacing chemical toxins with proven, plant-based solutions. With $6.4M in sales, no long-term debt, and expanding into 41 markets, the company is positioned to capture the surge in global demand for safer pest control.

As the world shifts to sustainable solutions, early investors could benefit from the same type of market recognition that transformed sectors led by innovators like Tesla and Zoom – only this time, in clean pest control.

Simpler. Safer. More Effective Pesticides.

Disclosures

This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results. Always consult a qualified financial professional before making investment decisions.

*PAID PROMOTION: Sherwood Ventures has been compensated two thousand four hundred fifty dollars for this communication on 4/19/2026 (via IMS) to increase public awareness of Med-x, Inc. We recommend that you do your own independent research before investing in anything, as private investing is risky and often illiquid. We believe in the companies we form affiliate relationships with, but please don’t invest any money unless you believe it will help you achieve your goals.